Literature DB >> 27276552

Biomanufacturing of Therapeutic Cells: State of the Art, Current Challenges, and Future Perspectives.

Kyung-Ho Roh1,2, Robert M Nerem2,3, Krishnendu Roy1,2.   

Abstract

Stem cells and other functionally defined therapeutic cells (e.g., T cells) are promising to bring hope of a permanent cure for diseases and disorders that currently cannot be cured by conventional drugs or biological molecules. This paradigm shift in modern medicine of using cells as novel therapeutics can be realized only if suitable manufacturing technologies for large-scale, cost-effective, reproducible production of high-quality cells can be developed. Here we review the state of the art in therapeutic cell manufacturing, including cell purification and isolation, activation and differentiation, genetic modification, expansion, packaging, and preservation. We identify current challenges and discuss opportunities to overcome them such that cell therapies become highly effective, safe, and predictively reproducible while at the same time becoming affordable and widely available.

Entities:  

Keywords:  T cell; biomanufacturing; cell therapy; scale-out; scale-up; stem cell

Mesh:

Year:  2016        PMID: 27276552     DOI: 10.1146/annurev-chembioeng-080615-033559

Source DB:  PubMed          Journal:  Annu Rev Chem Biomol Eng        ISSN: 1947-5438            Impact factor:   11.059


  21 in total

Review 1.  Manufacturing Cell Therapies Using Engineered Biomaterials.

Authors:  Amr A Abdeen; Krishanu Saha
Journal:  Trends Biotechnol       Date:  2017-07-12       Impact factor: 19.536

2.  Perspectives on Manufacturing of High-Quality Cell Therapies.

Authors:  Isabelle Rivière; Krishnendu Roy
Journal:  Mol Ther       Date:  2017-04-24       Impact factor: 11.454

3.  Essential design considerations for the resazurin reduction assay to noninvasively quantify cell expansion within perfused extracellular matrix scaffolds.

Authors:  Joseph S Uzarski; Michael D DiVito; Jason A Wertheim; William M Miller
Journal:  Biomaterials       Date:  2017-02-16       Impact factor: 12.479

4.  Massively-Parallelized, Deterministic Mechanoporation for Intracellular Delivery.

Authors:  Harish G Dixit; Renate Starr; Morgan L Dundon; Pranee I Pairs; Xin Yang; Yanyan Zhang; Daniel Nampe; Christopher B Ballas; Hideaki Tsutsui; Stephen J Forman; Christine E Brown; Masaru P Rao
Journal:  Nano Lett       Date:  2019-10-28       Impact factor: 11.189

5.  Lentiviral-based reporter constructs for profiling chondrogenic activity in primary equine cell populations.

Authors:  A Martin-Pena; R M Porter; G Plumton; T M McCarrel; A J Morton; M V Guijarro; S C Ghivizzani; B Sharma; G D Palmer
Journal:  Eur Cell Mater       Date:  2018-10-12       Impact factor: 3.942

6.  Dawn of Chimeric Antigen Receptor T Cell Therapy in Non-Hodgkin Lymphoma.

Authors:  Karlo Perica; Lia Palomba; Renier J Brentjens
Journal:  Adv Cell Gene Ther       Date:  2018-10-07

Review 7.  Therapeutic T cell engineering.

Authors:  Michel Sadelain; Isabelle Rivière; Stanley Riddell
Journal:  Nature       Date:  2017-05-24       Impact factor: 49.962

Review 8.  Mesenchymal Stem/Progenitor Cells: The Prospect of Human Clinical Translation.

Authors:  Dina Rady; Marwa M S Abbass; Aiah A El-Rashidy; Sara El Moshy; Israa Ahmed Radwan; Christof E Dörfer; Karim M Fawzy El-Sayed
Journal:  Stem Cells Int       Date:  2020-08-11       Impact factor: 5.443

9.  Sample-to-analysis platform for rapid intracellular mass spectrometry from small numbers of cells.

Authors:  Austin L Culberson; Mason A Chilmonczyk; Peter A Kottke; Annie C Bowles-Welch; Delta Ghoshal; Andrei G Fedorov
Journal:  Lab Chip       Date:  2021-11-25       Impact factor: 6.799

10.  Synergistic Development of Biochips and Cell Preservation Methodologies: A Tale of Converging Technologies.

Authors:  Shangping Wang; Gloria D Elliott
Journal:  Curr Stem Cell Rep       Date:  2017-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.